Related Topics >> Array BioPharma | inflammatory diseases | Drug Discovery | Cancer

SPOTLIGHT: Array lands $80M financing deal

May 6, 2008 — 6:59am ET

Hospira, Stada in pact to develop new biosimilar
Scripps Florida sees first biotech spinoff take root
Renovis pares work force in restructuring
Dutch biotech garners €15M in venture round
BMS sees positive outcome for cancer drug
GSK collaborates on immune disease research
Inimex raises $22M in VC
Italy's Newron buys U.K.-based developer
ALSO NOTED: Galenica share surge on committee approval; Progen to acquire CellGate; and much more...
Genzyme diarrhea drug fails Phase III

Tools

Email
Print
Comment
Contact Author

Deerfield Management will provide $80 million to Array BioPharma to fund its drug discovery work. Array is advancing new therapies for inflammatory diseases and cancer. Principal and interest of 6.5 percent a year accrue annually and are due in 2014. Release | Story

Be the first to comment

More stories about Array BioPharma inflammatory diseases Cancer

Comments

Post new comment

Paid Research Reports

RNA therapy: the next big thing after monoclonal antibodies?
Biotech M&A Strategies: Deal assessments, trends and future prospects
The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
Sales Force Effectiveness
Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage

More Research Reports >>

Most Popular Stories

Featured Jobs

Webinars

Popular Topics

Events

SPOTLIGHT: Array lands $80M financing deal

Related Stories

Comments

Post new comment

Paid Research Reports

THE FIERCEMARKETS NETWORK